Tuesday, June 30, 2026
ADVT 
National

Facebook lawsuit settling fee $51M

Darpan News Desk The Canadian Press, 11 Jan, 2024 04:59 PM
  • Facebook lawsuit settling fee $51M

Meta is offering $51 million to settle a class-action lawsuit in four Canadian provinces over the use of some users' images in Facebook advertising. 

The legal action filed by a B.C. woman claimed her image and those of others were used without their knowledge in Facebook's "sponsored stories" advertising program, which is no longer in operation.

MNP Ltd., the court-appointed administrator handling the proposed settlement, says in a statement the agreement needs to be approved by a B.C. Supreme Court judge in March, along with a process to determine class members’ share of the money. 

The lawsuit was expanded outside of B.C. in 2019 to include residents of Saskatchewan, Manitoba and Newfoundland and Labrador.

Sponsored stories ran from January 2011 to May 2014. If someone liked a product under the program, Facebook generated a news feed endorsement using their name and profile photo, but didn't tell them their image was being used.

"The proposed settlement provides that Facebook will pay the all-inclusive sum of $51 million in exchange for a full and final release by the class of all claims in issue in the class-action against Facebook," the statement issued Thursday by MNP said.

Lawyers estimate 4.3 million people who had their real name or photo used in a sponsored story could qualify as part of the Canadian settlement. 

Anyone who wants to object to the proposed settlement has until March 11.

The MNP statement said class members don't need to do anything yet to get compensation. 

"After settlement is approved, a process will be announced setting out the procedure and manner for class members to submit their claims for a share of the settlement funds."

MORE National ARTICLES

Protective equipment still scarce for some nurses

Protective equipment still scarce for some nurses
While early indications showed the virus was spread by droplets that settled on surfaces, Silas, president of the Canadian Federation of Nurses, urged health authorities to learn from the SARS outbreak of 2003 and take the highest level of precaution.    

Protective equipment still scarce for some nurses

COVID-19 hospitalizations to surge: Tam

COVID-19 hospitalizations to surge: Tam
Though the rate of people who are hospitalized with Omicron is lower compared to the Delta variant, the forecast shows new daily hospital admissions will far exceed previous historical peaks due to the sheer number of cases.

COVID-19 hospitalizations to surge: Tam

Omicron upends mathematical models tracking COVID

Omicron upends mathematical models tracking COVID
Everything from who gets tested to who's most likely to contract the virus has changed with the latest wave of the pandemic, and that's posing distinct challenges for those who model its impact, says Caroline Colijn, an associate professor of mathematics at Simon Fraser University in British Columbia.

Omicron upends mathematical models tracking COVID

O'Toole opposes Quebec's plan to tax unvaccinated

O'Toole opposes Quebec's plan to tax unvaccinated
The Tory leader made his position known on Premier François Legault's proposal during a Facebook Liveevent late Thursday. Some of his MPs had already taken to social media to condemn the proposal as discriminatory, unethical and punishing to low-income earners.

O'Toole opposes Quebec's plan to tax unvaccinated

B.C. funds OD prevention in construction industry

B.C. funds OD prevention in construction industry
Sheila Malcolmson, the minister of mental health and addictions, says the program dubbed the Tailgate Toolkit was developed on Vancouver Island last year in partnership with people in the industry who have experience with illicit drug use.    

B.C. funds OD prevention in construction industry

Health Canada decision on Pfizer antiviral close

Health Canada decision on Pfizer antiviral close
Canadian health leaders and some premiers have been publicly pressuring Health Canada to greenlight the medication, which prevents the SARS-CoV-2 virus that causes COVID-19 from reproducing within a patient's body. Pfizer's clinical trial showed for high-risk patients it prevented hospitalizations by about 90 per cent.

Health Canada decision on Pfizer antiviral close